Home 
Diseases Leishmaniasis Clinical Trial Protocols
Diseases Leishmaniasis Clinical Trial Protocols
Clinical Trial Protocol
Clinical Trial Protocols
VL Combination Therapy in Asia NCT01122771 - Phase III, Study of Three Short Course Combination Regimens (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome® Alone for the Treatment of Visceral Leishmaniasis in Bangladesh More NCT00696969 - Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis (India) More NCT00523965 - Combination Therapy in Indian Visceral Leishmaniasis More VL Combination Therapy in Africa NCT01067443 - Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa More NCT00832208 - Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With Visceral Leishmaniasis (Ethiopia) More NCT00255567 - Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis (Ethiopia, Kenya, Sudan Uganda) More VL in Latin America NCT01310738- Comparison of Drugs for VL treatment in Brazil Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (LVBrasil) More CL NCT00257530 - Imiquimod for Cutaneous Leishmaniasis Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis More |
Leishmaniasis
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License